nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—PSIP1—Vpr-mediated nuclear import of PICs—NUP205—Paget's disease of bone	0.0241	0.187	CbGpPWpGaD
L-DOPA—PSIP1—Interactions of Vpr with host cellular proteins—NUP205—Paget's disease of bone	0.0224	0.174	CbGpPWpGaD
L-DOPA—PSIP1—Host Interactions of HIV factors—NUP205—Paget's disease of bone	0.00786	0.061	CbGpPWpGaD
L-DOPA—PSIP1—HIV Life Cycle—NUP205—Paget's disease of bone	0.00739	0.0574	CbGpPWpGaD
L-DOPA—SLC7A8—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.0053	0.0411	CbGpPWpGaD
L-DOPA—PSIP1—HIV Infection—NUP205—Paget's disease of bone	0.0051	0.0396	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.00501	0.0389	CbGpPWpGaD
L-DOPA—SLC7A5—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.00462	0.0359	CbGpPWpGaD
L-DOPA—Neuropathy peripheral—Etidronic acid—Paget's disease of bone	0.00455	0.00522	CcSEcCtD
L-DOPA—Phlebitis—Pamidronate—Paget's disease of bone	0.00454	0.00521	CcSEcCtD
L-DOPA—Gastritis—Alendronate—Paget's disease of bone	0.00454	0.00521	CcSEcCtD
L-DOPA—Dysphagia—Alendronate—Paget's disease of bone	0.00443	0.00509	CcSEcCtD
L-DOPA—Asthenia—Tiludronate—Paget's disease of bone	0.00443	0.00509	CcSEcCtD
L-DOPA—Agranulocytosis—Etidronic acid—Paget's disease of bone	0.00433	0.00497	CcSEcCtD
L-DOPA—Diarrhoea—Tiludronate—Paget's disease of bone	0.00423	0.00485	CcSEcCtD
L-DOPA—Hallucination—Etidronic acid—Paget's disease of bone	0.00414	0.00476	CcSEcCtD
L-DOPA—Sleep disorder—Zoledronate—Paget's disease of bone	0.00413	0.00474	CcSEcCtD
L-DOPA—Pain in extremity—Risedronate—Paget's disease of bone	0.00412	0.00473	CcSEcCtD
L-DOPA—Dizziness—Tiludronate—Paget's disease of bone	0.00409	0.00469	CcSEcCtD
L-DOPA—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.00391	0.00449	CcSEcCtD
L-DOPA—Headache—Tiludronate—Paget's disease of bone	0.00387	0.00444	CcSEcCtD
L-DOPA—Psychotic disorder—Pamidronate—Paget's disease of bone	0.00382	0.00439	CcSEcCtD
L-DOPA—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00368	0.00423	CcSEcCtD
L-DOPA—Alopecia—Etidronic acid—Paget's disease of bone	0.00368	0.00423	CcSEcCtD
L-DOPA—Nausea—Tiludronate—Paget's disease of bone	0.00367	0.00421	CcSEcCtD
L-DOPA—Blood creatinine increased—Pamidronate—Paget's disease of bone	0.00367	0.00421	CcSEcCtD
L-DOPA—Gastritis—Risedronate—Paget's disease of bone	0.00364	0.00418	CcSEcCtD
L-DOPA—Pain in extremity—Zoledronate—Paget's disease of bone	0.00357	0.0041	CcSEcCtD
L-DOPA—Flatulence—Etidronic acid—Paget's disease of bone	0.00357	0.0041	CcSEcCtD
L-DOPA—Haemoglobin—Alendronate—Paget's disease of bone	0.00357	0.0041	CcSEcCtD
L-DOPA—Haemorrhage—Alendronate—Paget's disease of bone	0.00355	0.00407	CcSEcCtD
L-DOPA—Cramp muscle—Pamidronate—Paget's disease of bone	0.00352	0.00405	CcSEcCtD
L-DOPA—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.0035	0.00402	CcSEcCtD
L-DOPA—Muscle spasms—Etidronic acid—Paget's disease of bone	0.00349	0.004	CcSEcCtD
L-DOPA—Angina pectoris—Risedronate—Paget's disease of bone	0.00347	0.00398	CcSEcCtD
L-DOPA—Gastritis—Pamidronate—Paget's disease of bone	0.00346	0.00398	CcSEcCtD
L-DOPA—Anaemia—Etidronic acid—Paget's disease of bone	0.00335	0.00385	CcSEcCtD
L-DOPA—Blood creatinine increased—Zoledronate—Paget's disease of bone	0.00335	0.00384	CcSEcCtD
L-DOPA—Angioedema—Etidronic acid—Paget's disease of bone	0.00331	0.0038	CcSEcCtD
L-DOPA—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00331	0.0038	CcSEcCtD
L-DOPA—Sweating increased—Pamidronate—Paget's disease of bone	0.00329	0.00378	CcSEcCtD
L-DOPA—Leukopenia—Etidronic acid—Paget's disease of bone	0.00325	0.00373	CcSEcCtD
L-DOPA—Cramp muscle—Zoledronate—Paget's disease of bone	0.00322	0.0037	CcSEcCtD
L-DOPA—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.0032	0.00367	CcSEcCtD
L-DOPA—Gastritis—Zoledronate—Paget's disease of bone	0.00316	0.00363	CcSEcCtD
L-DOPA—Depression—Risedronate—Paget's disease of bone	0.00316	0.00363	CcSEcCtD
L-DOPA—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00314	0.00361	CcSEcCtD
L-DOPA—Alopecia—Alendronate—Paget's disease of bone	0.00314	0.0036	CcSEcCtD
L-DOPA—Dysphagia—Zoledronate—Paget's disease of bone	0.00309	0.00355	CcSEcCtD
L-DOPA—Urinary tract infection—Risedronate—Paget's disease of bone	0.00308	0.00354	CcSEcCtD
L-DOPA—Discomfort—Etidronic acid—Paget's disease of bone	0.00305	0.0035	CcSEcCtD
L-DOPA—Flatulence—Alendronate—Paget's disease of bone	0.00304	0.00349	CcSEcCtD
L-DOPA—Dysgeusia—Alendronate—Paget's disease of bone	0.00303	0.00347	CcSEcCtD
L-DOPA—Sweating increased—Zoledronate—Paget's disease of bone	0.00301	0.00345	CcSEcCtD
L-DOPA—Confusional state—Etidronic acid—Paget's disease of bone	0.00298	0.00343	CcSEcCtD
L-DOPA—Muscle spasms—Alendronate—Paget's disease of bone	0.00297	0.00341	CcSEcCtD
L-DOPA—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00293	0.00337	CcSEcCtD
L-DOPA—DRD4—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.00291	0.0226	CbGpPWpGaD
L-DOPA—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00287	0.0033	CcSEcCtD
L-DOPA—SLC7A8—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00287	0.0223	CbGpPWpGaD
L-DOPA—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00287	0.00329	CcSEcCtD
L-DOPA—Haemoglobin—Risedronate—Paget's disease of bone	0.00286	0.00329	CcSEcCtD
L-DOPA—Anaemia—Alendronate—Paget's disease of bone	0.00286	0.00328	CcSEcCtD
L-DOPA—Rhinitis—Risedronate—Paget's disease of bone	0.00286	0.00328	CcSEcCtD
L-DOPA—Pollakiuria—Zoledronate—Paget's disease of bone	0.00285	0.00328	CcSEcCtD
L-DOPA—Haemorrhage—Risedronate—Paget's disease of bone	0.00285	0.00327	CcSEcCtD
L-DOPA—Angioedema—Alendronate—Paget's disease of bone	0.00282	0.00324	CcSEcCtD
L-DOPA—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00281	0.00323	CcSEcCtD
L-DOPA—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00281	0.00323	CcSEcCtD
L-DOPA—Weight increased—Zoledronate—Paget's disease of bone	0.00281	0.00323	CcSEcCtD
L-DOPA—Weight decreased—Zoledronate—Paget's disease of bone	0.0028	0.00321	CcSEcCtD
L-DOPA—Urethral disorder—Risedronate—Paget's disease of bone	0.00279	0.0032	CcSEcCtD
L-DOPA—Malaise—Alendronate—Paget's disease of bone	0.00279	0.0032	CcSEcCtD
L-DOPA—Depression—Zoledronate—Paget's disease of bone	0.00275	0.00315	CcSEcCtD
L-DOPA—Haemoglobin—Pamidronate—Paget's disease of bone	0.00272	0.00312	CcSEcCtD
L-DOPA—Rhinitis—Pamidronate—Paget's disease of bone	0.00271	0.00312	CcSEcCtD
L-DOPA—Haemorrhage—Pamidronate—Paget's disease of bone	0.00271	0.00311	CcSEcCtD
L-DOPA—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00268	0.00307	CcSEcCtD
L-DOPA—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00267	0.00307	CcSEcCtD
L-DOPA—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00266	0.00305	CcSEcCtD
L-DOPA—Urethral disorder—Pamidronate—Paget's disease of bone	0.00265	0.00305	CcSEcCtD
L-DOPA—Chest pain—Alendronate—Paget's disease of bone	0.00263	0.00302	CcSEcCtD
L-DOPA—DRD1—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.00262	0.0203	CbGpPWpGaD
L-DOPA—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00261	0.00299	CcSEcCtD
L-DOPA—Discomfort—Alendronate—Paget's disease of bone	0.0026	0.00298	CcSEcCtD
L-DOPA—DRD3—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.00258	0.0201	CbGpPWpGaD
L-DOPA—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00257	0.00295	CcSEcCtD
L-DOPA—Arrhythmia—Risedronate—Paget's disease of bone	0.00254	0.00292	CcSEcCtD
L-DOPA—Constipation—Etidronic acid—Paget's disease of bone	0.00253	0.00291	CcSEcCtD
L-DOPA—Flushing—Pamidronate—Paget's disease of bone	0.00251	0.00288	CcSEcCtD
L-DOPA—SLC7A5—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.0025	0.0194	CbGpPWpGaD
L-DOPA—Mental disorder—Risedronate—Paget's disease of bone	0.0025	0.00286	CcSEcCtD
L-DOPA—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00246	0.00282	CcSEcCtD
L-DOPA—Flatulence—Risedronate—Paget's disease of bone	0.00244	0.0028	CcSEcCtD
L-DOPA—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00244	0.0028	CcSEcCtD
L-DOPA—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00244	0.0028	CcSEcCtD
L-DOPA—Urethral disorder—Zoledronate—Paget's disease of bone	0.00242	0.00278	CcSEcCtD
L-DOPA—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00242	0.00278	CcSEcCtD
L-DOPA—Back pain—Risedronate—Paget's disease of bone	0.0024	0.00275	CcSEcCtD
L-DOPA—Alopecia—Pamidronate—Paget's disease of bone	0.00239	0.00275	CcSEcCtD
L-DOPA—Muscle spasms—Risedronate—Paget's disease of bone	0.00238	0.00274	CcSEcCtD
L-DOPA—Urticaria—Etidronic acid—Paget's disease of bone	0.00235	0.0027	CcSEcCtD
L-DOPA—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00234	0.00269	CcSEcCtD
L-DOPA—Tension—Pamidronate—Paget's disease of bone	0.00231	0.00265	CcSEcCtD
L-DOPA—Dysgeusia—Pamidronate—Paget's disease of bone	0.00231	0.00265	CcSEcCtD
L-DOPA—Flushing—Zoledronate—Paget's disease of bone	0.0023	0.00263	CcSEcCtD
L-DOPA—Anaemia—Risedronate—Paget's disease of bone	0.00229	0.00263	CcSEcCtD
L-DOPA—Nervousness—Pamidronate—Paget's disease of bone	0.00229	0.00263	CcSEcCtD
L-DOPA—Back pain—Pamidronate—Paget's disease of bone	0.00228	0.00262	CcSEcCtD
L-DOPA—Muscle spasms—Pamidronate—Paget's disease of bone	0.00227	0.0026	CcSEcCtD
L-DOPA—Angioedema—Risedronate—Paget's disease of bone	0.00227	0.0026	CcSEcCtD
L-DOPA—Syncope—Risedronate—Paget's disease of bone	0.00222	0.00255	CcSEcCtD
L-DOPA—Dyspepsia—Alendronate—Paget's disease of bone	0.00222	0.00255	CcSEcCtD
L-DOPA—Arrhythmia—Zoledronate—Paget's disease of bone	0.00221	0.00254	CcSEcCtD
L-DOPA—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00219	0.00251	CcSEcCtD
L-DOPA—Alopecia—Zoledronate—Paget's disease of bone	0.00219	0.00251	CcSEcCtD
L-DOPA—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00218	0.0025	CcSEcCtD
L-DOPA—Loss of consciousness—Risedronate—Paget's disease of bone	0.00218	0.0025	CcSEcCtD
L-DOPA—Anaemia—Pamidronate—Paget's disease of bone	0.00218	0.0025	CcSEcCtD
L-DOPA—Mental disorder—Zoledronate—Paget's disease of bone	0.00217	0.00249	CcSEcCtD
L-DOPA—Agitation—Pamidronate—Paget's disease of bone	0.00217	0.00249	CcSEcCtD
L-DOPA—Cough—Risedronate—Paget's disease of bone	0.00216	0.00248	CcSEcCtD
L-DOPA—Constipation—Alendronate—Paget's disease of bone	0.00216	0.00248	CcSEcCtD
L-DOPA—Pain—Alendronate—Paget's disease of bone	0.00216	0.00248	CcSEcCtD
L-DOPA—Angioedema—Pamidronate—Paget's disease of bone	0.00215	0.00247	CcSEcCtD
L-DOPA—Hypertension—Risedronate—Paget's disease of bone	0.00214	0.00246	CcSEcCtD
L-DOPA—Malaise—Pamidronate—Paget's disease of bone	0.00213	0.00244	CcSEcCtD
L-DOPA—Syncope—Pamidronate—Paget's disease of bone	0.00211	0.00243	CcSEcCtD
L-DOPA—Chest pain—Risedronate—Paget's disease of bone	0.00211	0.00242	CcSEcCtD
L-DOPA—Leukopenia—Pamidronate—Paget's disease of bone	0.00211	0.00242	CcSEcCtD
L-DOPA—Dysgeusia—Zoledronate—Paget's disease of bone	0.00211	0.00242	CcSEcCtD
L-DOPA—Anxiety—Risedronate—Paget's disease of bone	0.0021	0.00241	CcSEcCtD
L-DOPA—Pruritus—Etidronic acid—Paget's disease of bone	0.00209	0.0024	CcSEcCtD
L-DOPA—Back pain—Zoledronate—Paget's disease of bone	0.00208	0.00239	CcSEcCtD
L-DOPA—Feeling abnormal—Alendronate—Paget's disease of bone	0.00208	0.00239	CcSEcCtD
L-DOPA—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00207	0.00238	CcSEcCtD
L-DOPA—Muscle spasms—Zoledronate—Paget's disease of bone	0.00207	0.00238	CcSEcCtD
L-DOPA—Dry mouth—Risedronate—Paget's disease of bone	0.00206	0.00237	CcSEcCtD
L-DOPA—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00206	0.00237	CcSEcCtD
L-DOPA—Cough—Pamidronate—Paget's disease of bone	0.00206	0.00236	CcSEcCtD
L-DOPA—Convulsion—Pamidronate—Paget's disease of bone	0.00204	0.00234	CcSEcCtD
L-DOPA—Hypertension—Pamidronate—Paget's disease of bone	0.00203	0.00234	CcSEcCtD
L-DOPA—Vision blurred—Zoledronate—Paget's disease of bone	0.00203	0.00233	CcSEcCtD
L-DOPA—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00202	0.00232	CcSEcCtD
L-DOPA—Tremor—Zoledronate—Paget's disease of bone	0.00202	0.00232	CcSEcCtD
L-DOPA—Urticaria—Alendronate—Paget's disease of bone	0.002	0.0023	CcSEcCtD
L-DOPA—Anxiety—Pamidronate—Paget's disease of bone	0.002	0.0023	CcSEcCtD
L-DOPA—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.002	0.00229	CcSEcCtD
L-DOPA—Abdominal pain—Alendronate—Paget's disease of bone	0.00199	0.00229	CcSEcCtD
L-DOPA—Shock—Risedronate—Paget's disease of bone	0.00199	0.00229	CcSEcCtD
L-DOPA—Anaemia—Zoledronate—Paget's disease of bone	0.00199	0.00228	CcSEcCtD
L-DOPA—Discomfort—Pamidronate—Paget's disease of bone	0.00198	0.00228	CcSEcCtD
L-DOPA—Agitation—Zoledronate—Paget's disease of bone	0.00198	0.00227	CcSEcCtD
L-DOPA—DRD2—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.00198	0.0153	CbGpPWpGaD
L-DOPA—Angioedema—Zoledronate—Paget's disease of bone	0.00197	0.00226	CcSEcCtD
L-DOPA—DDC—Circadian rythm related genes—PML—Paget's disease of bone	0.00195	0.0151	CbGpPWpGaD
L-DOPA—Malaise—Zoledronate—Paget's disease of bone	0.00194	0.00223	CcSEcCtD
L-DOPA—Confusional state—Pamidronate—Paget's disease of bone	0.00194	0.00223	CcSEcCtD
L-DOPA—Syncope—Zoledronate—Paget's disease of bone	0.00193	0.00222	CcSEcCtD
L-DOPA—Leukopenia—Zoledronate—Paget's disease of bone	0.00193	0.00221	CcSEcCtD
L-DOPA—Oedema—Pamidronate—Paget's disease of bone	0.00192	0.00221	CcSEcCtD
L-DOPA—Palpitations—Zoledronate—Paget's disease of bone	0.0019	0.00218	CcSEcCtD
L-DOPA—Shock—Pamidronate—Paget's disease of bone	0.00189	0.00217	CcSEcCtD
L-DOPA—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00189	0.00217	CcSEcCtD
L-DOPA—DRD5—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00189	0.0147	CbGpPWpGaD
L-DOPA—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00188	0.00216	CcSEcCtD
L-DOPA—Vomiting—Etidronic acid—Paget's disease of bone	0.00188	0.00216	CcSEcCtD
L-DOPA—Cough—Zoledronate—Paget's disease of bone	0.00188	0.00216	CcSEcCtD
L-DOPA—Rash—Etidronic acid—Paget's disease of bone	0.00187	0.00214	CcSEcCtD
L-DOPA—Convulsion—Zoledronate—Paget's disease of bone	0.00187	0.00214	CcSEcCtD
L-DOPA—Dermatitis—Etidronic acid—Paget's disease of bone	0.00186	0.00214	CcSEcCtD
L-DOPA—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00186	0.00213	CcSEcCtD
L-DOPA—Hypertension—Zoledronate—Paget's disease of bone	0.00186	0.00213	CcSEcCtD
L-DOPA—Hypersensitivity—Alendronate—Paget's disease of bone	0.00186	0.00213	CcSEcCtD
L-DOPA—Headache—Etidronic acid—Paget's disease of bone	0.00185	0.00213	CcSEcCtD
L-DOPA—Anorexia—Pamidronate—Paget's disease of bone	0.00183	0.0021	CcSEcCtD
L-DOPA—Chest pain—Zoledronate—Paget's disease of bone	0.00183	0.0021	CcSEcCtD
L-DOPA—Insomnia—Risedronate—Paget's disease of bone	0.00183	0.0021	CcSEcCtD
L-DOPA—Anxiety—Zoledronate—Paget's disease of bone	0.00183	0.0021	CcSEcCtD
L-DOPA—Paraesthesia—Risedronate—Paget's disease of bone	0.00182	0.00209	CcSEcCtD
L-DOPA—Discomfort—Zoledronate—Paget's disease of bone	0.00181	0.00208	CcSEcCtD
L-DOPA—Asthenia—Alendronate—Paget's disease of bone	0.00181	0.00208	CcSEcCtD
L-DOPA—Dyspnoea—Risedronate—Paget's disease of bone	0.0018	0.00207	CcSEcCtD
L-DOPA—Hypotension—Pamidronate—Paget's disease of bone	0.0018	0.00206	CcSEcCtD
L-DOPA—Dry mouth—Zoledronate—Paget's disease of bone	0.00179	0.00206	CcSEcCtD
L-DOPA—Pruritus—Alendronate—Paget's disease of bone	0.00178	0.00205	CcSEcCtD
L-DOPA—Dyspepsia—Risedronate—Paget's disease of bone	0.00178	0.00204	CcSEcCtD
L-DOPA—Confusional state—Zoledronate—Paget's disease of bone	0.00177	0.00203	CcSEcCtD
L-DOPA—Nausea—Etidronic acid—Paget's disease of bone	0.00176	0.00202	CcSEcCtD
L-DOPA—Oedema—Zoledronate—Paget's disease of bone	0.00176	0.00202	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00175	0.00201	CcSEcCtD
L-DOPA—Fatigue—Risedronate—Paget's disease of bone	0.00174	0.002	CcSEcCtD
L-DOPA—Insomnia—Pamidronate—Paget's disease of bone	0.00174	0.002	CcSEcCtD
L-DOPA—Constipation—Risedronate—Paget's disease of bone	0.00173	0.00199	CcSEcCtD
L-DOPA—Pain—Risedronate—Paget's disease of bone	0.00173	0.00199	CcSEcCtD
L-DOPA—Shock—Zoledronate—Paget's disease of bone	0.00173	0.00198	CcSEcCtD
L-DOPA—Paraesthesia—Pamidronate—Paget's disease of bone	0.00173	0.00198	CcSEcCtD
L-DOPA—Diarrhoea—Alendronate—Paget's disease of bone	0.00173	0.00198	CcSEcCtD
L-DOPA—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00172	0.00197	CcSEcCtD
L-DOPA—Dyspnoea—Pamidronate—Paget's disease of bone	0.00171	0.00197	CcSEcCtD
L-DOPA—Somnolence—Pamidronate—Paget's disease of bone	0.00171	0.00196	CcSEcCtD
L-DOPA—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.0017	0.00195	CcSEcCtD
L-DOPA—Dyspepsia—Pamidronate—Paget's disease of bone	0.00169	0.00194	CcSEcCtD
L-DOPA—Anorexia—Zoledronate—Paget's disease of bone	0.00167	0.00192	CcSEcCtD
L-DOPA—Decreased appetite—Pamidronate—Paget's disease of bone	0.00167	0.00192	CcSEcCtD
L-DOPA—Dizziness—Alendronate—Paget's disease of bone	0.00167	0.00191	CcSEcCtD
L-DOPA—SLC16A10—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00166	0.0129	CbGpPWpGaD
L-DOPA—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00166	0.00191	CcSEcCtD
L-DOPA—Fatigue—Pamidronate—Paget's disease of bone	0.00166	0.0019	CcSEcCtD
L-DOPA—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00165	0.0019	CcSEcCtD
L-DOPA—Constipation—Pamidronate—Paget's disease of bone	0.00164	0.00189	CcSEcCtD
L-DOPA—Pain—Pamidronate—Paget's disease of bone	0.00164	0.00189	CcSEcCtD
L-DOPA—Hypotension—Zoledronate—Paget's disease of bone	0.00164	0.00188	CcSEcCtD
L-DOPA—PSIP1—Disease—VCP—Paget's disease of bone	0.00164	0.0127	CbGpPWpGaD
L-DOPA—Urticaria—Risedronate—Paget's disease of bone	0.00161	0.00185	CcSEcCtD
L-DOPA—Vomiting—Alendronate—Paget's disease of bone	0.0016	0.00184	CcSEcCtD
L-DOPA—Abdominal pain—Risedronate—Paget's disease of bone	0.0016	0.00184	CcSEcCtD
L-DOPA—Rash—Alendronate—Paget's disease of bone	0.00159	0.00183	CcSEcCtD
L-DOPA—Insomnia—Zoledronate—Paget's disease of bone	0.00159	0.00182	CcSEcCtD
L-DOPA—Dermatitis—Alendronate—Paget's disease of bone	0.00159	0.00182	CcSEcCtD
L-DOPA—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00159	0.00182	CcSEcCtD
L-DOPA—Headache—Alendronate—Paget's disease of bone	0.00158	0.00181	CcSEcCtD
L-DOPA—Paraesthesia—Zoledronate—Paget's disease of bone	0.00158	0.00181	CcSEcCtD
L-DOPA—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00157	0.00181	CcSEcCtD
L-DOPA—Dyspnoea—Zoledronate—Paget's disease of bone	0.00157	0.0018	CcSEcCtD
L-DOPA—Somnolence—Zoledronate—Paget's disease of bone	0.00156	0.00179	CcSEcCtD
L-DOPA—Dyspepsia—Zoledronate—Paget's disease of bone	0.00155	0.00178	CcSEcCtD
L-DOPA—Decreased appetite—Zoledronate—Paget's disease of bone	0.00153	0.00175	CcSEcCtD
L-DOPA—Abdominal pain—Pamidronate—Paget's disease of bone	0.00152	0.00175	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00152	0.00174	CcSEcCtD
L-DOPA—Fatigue—Zoledronate—Paget's disease of bone	0.00151	0.00174	CcSEcCtD
L-DOPA—Constipation—Zoledronate—Paget's disease of bone	0.0015	0.00172	CcSEcCtD
L-DOPA—Pain—Zoledronate—Paget's disease of bone	0.0015	0.00172	CcSEcCtD
L-DOPA—Nausea—Alendronate—Paget's disease of bone	0.0015	0.00172	CcSEcCtD
L-DOPA—Hypersensitivity—Risedronate—Paget's disease of bone	0.00149	0.00171	CcSEcCtD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.00146	0.0113	CbGpPWpGaD
L-DOPA—Asthenia—Risedronate—Paget's disease of bone	0.00145	0.00167	CcSEcCtD
L-DOPA—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00145	0.00166	CcSEcCtD
L-DOPA—SLC7A8—Hemostasis—INPP5D—Paget's disease of bone	0.00144	0.0112	CbGpPWpGaD
L-DOPA—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00144	0.00165	CcSEcCtD
L-DOPA—Pruritus—Risedronate—Paget's disease of bone	0.00143	0.00164	CcSEcCtD
L-DOPA—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00142	0.00163	CcSEcCtD
L-DOPA—Urticaria—Zoledronate—Paget's disease of bone	0.0014	0.0016	CcSEcCtD
L-DOPA—Abdominal pain—Zoledronate—Paget's disease of bone	0.00139	0.00159	CcSEcCtD
L-DOPA—Diarrhoea—Risedronate—Paget's disease of bone	0.00138	0.00159	CcSEcCtD
L-DOPA—Asthenia—Pamidronate—Paget's disease of bone	0.00138	0.00158	CcSEcCtD
L-DOPA—Pruritus—Pamidronate—Paget's disease of bone	0.00136	0.00156	CcSEcCtD
L-DOPA—Dizziness—Risedronate—Paget's disease of bone	0.00134	0.00154	CcSEcCtD
L-DOPA—Diarrhoea—Pamidronate—Paget's disease of bone	0.00132	0.00151	CcSEcCtD
L-DOPA—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00129	0.00149	CcSEcCtD
L-DOPA—SLC15A1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00129	0.01	CbGpPWpGaD
L-DOPA—Vomiting—Risedronate—Paget's disease of bone	0.00129	0.00148	CcSEcCtD
L-DOPA—Rash—Risedronate—Paget's disease of bone	0.00128	0.00146	CcSEcCtD
L-DOPA—Dermatitis—Risedronate—Paget's disease of bone	0.00127	0.00146	CcSEcCtD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.00127	0.00988	CbGpPWpGaD
L-DOPA—Dizziness—Pamidronate—Paget's disease of bone	0.00127	0.00146	CcSEcCtD
L-DOPA—Headache—Risedronate—Paget's disease of bone	0.00127	0.00146	CcSEcCtD
L-DOPA—Asthenia—Zoledronate—Paget's disease of bone	0.00126	0.00145	CcSEcCtD
L-DOPA—DRD1—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.00126	0.00975	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—INPP5D—Paget's disease of bone	0.00125	0.00973	CbGpPWpGaD
L-DOPA—PSIP1—Disease—NUP205—Paget's disease of bone	0.00125	0.00971	CbGpPWpGaD
L-DOPA—Pruritus—Zoledronate—Paget's disease of bone	0.00124	0.00143	CcSEcCtD
L-DOPA—Vomiting—Pamidronate—Paget's disease of bone	0.00122	0.0014	CcSEcCtD
L-DOPA—Rash—Pamidronate—Paget's disease of bone	0.00121	0.00139	CcSEcCtD
L-DOPA—Dermatitis—Pamidronate—Paget's disease of bone	0.00121	0.00139	CcSEcCtD
L-DOPA—Headache—Pamidronate—Paget's disease of bone	0.00121	0.00138	CcSEcCtD
L-DOPA—Diarrhoea—Zoledronate—Paget's disease of bone	0.0012	0.00138	CcSEcCtD
L-DOPA—Nausea—Risedronate—Paget's disease of bone	0.0012	0.00138	CcSEcCtD
L-DOPA—Dizziness—Zoledronate—Paget's disease of bone	0.00116	0.00133	CcSEcCtD
L-DOPA—Nausea—Pamidronate—Paget's disease of bone	0.00114	0.00131	CcSEcCtD
L-DOPA—DRD4—Circadian rythm related genes—PML—Paget's disease of bone	0.00113	0.00876	CbGpPWpGaD
L-DOPA—Vomiting—Zoledronate—Paget's disease of bone	0.00112	0.00128	CcSEcCtD
L-DOPA—Rash—Zoledronate—Paget's disease of bone	0.00111	0.00127	CcSEcCtD
L-DOPA—Dermatitis—Zoledronate—Paget's disease of bone	0.00111	0.00127	CcSEcCtD
L-DOPA—Headache—Zoledronate—Paget's disease of bone	0.0011	0.00126	CcSEcCtD
L-DOPA—Nausea—Zoledronate—Paget's disease of bone	0.00104	0.0012	CcSEcCtD
L-DOPA—DRD1—Circadian rythm related genes—PML—Paget's disease of bone	0.00102	0.00788	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—PML—Paget's disease of bone	0.001	0.00778	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CALCA—Paget's disease of bone	0.000928	0.00721	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000846	0.00657	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—PML—Paget's disease of bone	0.000767	0.00595	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—CALCA—Paget's disease of bone	0.000686	0.00533	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000657	0.0051	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CALCA—Paget's disease of bone	0.000506	0.00393	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CALCA—Paget's disease of bone	0.000456	0.00354	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CALCA—Paget's disease of bone	0.00045	0.00349	CbGpPWpGaD
L-DOPA—DDC—Metabolism—NUP205—Paget's disease of bone	0.000426	0.00331	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000388	0.00301	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—VCP—Paget's disease of bone	0.000367	0.00285	CbGpPWpGaD
L-DOPA—DDC—Metabolism—INPP5D—Paget's disease of bone	0.000364	0.00282	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CALCA—Paget's disease of bone	0.000352	0.00273	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CALCA—Paget's disease of bone	0.000344	0.00267	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000286	0.00222	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—VCP—Paget's disease of bone	0.000271	0.0021	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CALCA—Paget's disease of bone	0.00026	0.00202	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000258	0.002	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000254	0.00197	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—VCP—Paget's disease of bone	0.000244	0.00189	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—VCP—Paget's disease of bone	0.00024	0.00187	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CALCA—Paget's disease of bone	0.000234	0.00182	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CALCA—Paget's disease of bone	0.000231	0.00179	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000214	0.00166	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CALCA—Paget's disease of bone	0.000208	0.00161	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000194	0.00151	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VCP—Paget's disease of bone	0.000184	0.00143	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CALCA—Paget's disease of bone	0.000177	0.00137	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000158	0.00123	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CALCA—Paget's disease of bone	0.000153	0.00119	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000142	0.0011	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00014	0.00109	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CALCA—Paget's disease of bone	0.000138	0.00107	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CALCA—Paget's disease of bone	0.000136	0.00106	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000107	0.000834	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALCA—Paget's disease of bone	0.000104	0.00081	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NUP205—Paget's disease of bone	9.8e-05	0.000761	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	8.36e-05	0.000649	CbGpPWpGaD
